Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines

Journal of Pharmaceutical Sciences

Volumn 98, Issue 4, 2009, Pages 1409-1425

  Vad, Nikhil M ^a   Yount, Garret ^b   Moore, Dan ^b,c   Weidanz, Jom ^a   Moridan, Majid Y ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOSPORIN A; DICOUMAROL; GLUTATHIONE; HEPTANE DERIVATIVE; MONOPHENOL MONOOXYGENASE; PARACETAMOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRIFLUOPERAZINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; MALE; MELANOMA B16; MELANOMA CELL; MITOCHONDRIAL TOXICITY; NONHUMAN; OXIDATION; RAT;

EID: 67349285976     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21505     Document Type: Article

References (41)

1. Smit NP, Peters K, Menko W, Westerhof W, Pavel S, Riley PA. 1992. Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells. Melanoma Res 2:295-304.
2. Kern DH, Shoemaker RH, Hildebrand-Zanki SU, Driscoll JS. 1988. Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma. Cancer Res 48:5178-5182.
3. Naish-Byfield S, Cooksey CJ, Latter AM, Johnson CI, Riley PA. 1991. In vitro assessment of the structure-activity relationship of tyrosinase-dependent cytotoxicity of a series of substituted phenols. Melanoma Res 1:273-287.
4. Riley PA. 1969. Hydroxyanisole depigmentation: In-vitro studies. J Pathol 97:193-206.
5. Naish S, Holden JL, Cooksey CJ, Riley PA. 1988. Major primary cytotoxic product of 4-hydroxyanisole oxidation by mushroom tyrosinase is 4-methoxy ortho benzoquinone. Pigment Cell Res 1:382-385.
6. Naish S, Cooksey CJ, Riley PA. 1988. Initial mushroom tyrosinase-catalysed oxidation product of 4-hydroxyanisole is 4-methoxy-ortho-benzoquinone. Pigment Cell Res 1:379-381.
7. Moridani MY, Cheon SS, Khan S, O'Brien PJ. 2002. Metabolic activation of 4-hydroxyanisole by isolated rat hepatocytes. Drug Metab Dispos 30:1063-1069.
8. Ruštin GJ, Stratford MR, Lamont A, Bleehen N, Philip PA, Howells N, Watfa RR, Slack JA. 1992. Phase I study of intravenous 4-hydroxyanisole. Eur J Cancer 28:1362-1364.
9. Moridani MY. 2006. Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-FO melanoma cells. Cancer Lett 243:235-245.
10. Jackson Roberts L, Jason II, Morrow D. 2001. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Gilman AG, editors. The Pharmacological Basis of Therapeutics, 10th edition. USA: McGraw-Hill. p. 687.
11. Wolchok JD, Williams L, Pinto JT, Fleisher M, Krown SE, Hwu W-J, Livingston PO, Chang C, Chapman PB. 2003. Phase I trial of high dose paracetamol and carmustine in patients with meta-static melanoma. Melanoma Res 13:189-196.
12. Valero E, Carrion P, Varon R, Garcia-Carmona F. 2003. Quantification of acetaminophen by oxidation with tyrosinase in the presence of besthorn's hydrazone. Anal Biochem 318:187-195.
13. Valero E, Varon R, Garcia-Carmona F. 2003. Catalytic oxidation of acetaminophen by tyrosinase in the presence of L-proline: A kinetic study. Arch Biochem Biophys 416:218-226.
14. Valero E, Varon R, Garcia-Carmona F. 2002. Tyrosinase-mediated oxidation of acetaminophen to 4-acetamido-o-benzoquinone. Biol Chem 383: 1931-1939.
15. Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77.
16. Moridani MY, Moore M, Bartsch RA, Yang Y, Heibati-Sadati S. 2005. Structural toxicity relationship of 4-alkoxyphenols' cytotoxicity towards murine B16-FO melanoma cell line. J Pharm Pharm Sei 8:348-360.
17. GergeP D, Cederbaum AI. 1997. Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: Implications for the determination of free sulfhydryl groups by ellman's reagent. Arch Biochem Biophys 347:282-288.
18. Krikun G, Cederbaum AI. 1984. Increased micro- somal oxidation of alcohols after pyrazole treatment and its similarities to the induction by ethanol consumption. Biochim Biophys Acta 801:131-137.
19. Dallner G. 1978. Isolation of microsomal subfractions by use of density gradients. Methods Enzymol 52:71-82.
20. Kruger NJ. 1994. The bradford method for protein quantitation. Methods MoI Biol 32:9-15.
21. Wu X, Zeng H, Zhang X, Zhao Y, Sha H, Ge X, Zhang M, Gao X, Xu Q. 2004. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164: 2039-2054.
22. Moridani MY, Cheon SS, Khan S, O'Brien PJ. 2003. Metabolic activation of 3-hydroxyanisole by isolated rat hepatocytes. Chem Biol Interact 142:317-333.
23. Shaik IH, Mehvar R. 2006. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: Application to the rat liver and bile samples. Anal Bioanal Chem 385:105-113.
24. Siraki AG, Chan TS, O'Brien PJ. 2004. Application of quantitative structure-toxicity relationships for the comparison of the cytotoxicity of 14 p-benzoquinone congeners in primary cultured rat hepatocytes versus PC12 cells. Toxicol Sei 81:148-159.
25. Preusch PC, Siegel D, Gibson NW, Ross D. 1991. A note on the inhibition of DT-diaphorase by dicoumarol. Free Radie Biol Med 11:77-80.
26. Khan S, O'Brien PJ. 1991. 1-bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem Biophys Res Commun 179:436-441.
27. Broekemeier KM, Pfeiffer DR. 1989. Cyclosporin A-sensitive and insensitive mechanisms produce the permeability transition in mitochondria. Biochem Biophys Res Commun 163:561-566.
28. Riley PA, Cooksey CJ, Johnson CI, Land EJ, Latter AM, Ramsden CA. 1997. Melanogenesis-targeted anti-melanoma pro-drug development: Effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. Eur J Cancer 33:135-143.
29. Anasagasti MJ, Martin JJ, Mendoza L, Obrador E, Estrela JM, McCuskey RS, Vidal-VanaclochaF. 1998. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 27:1249-1256.
30. Mitchell DB, Acosta D, Bruckner JV. 1985. Role of Glutathione depletion in the cytotoxicity of Acetaminophen in a primary culture system of rat hepatocytes. Toxicology 37:127-146.
31. Viña J, Romero FJ, Estrela JM, Viña JR. 1980. Effect of acetaminophen (paracetamol) and its antagonists on glutathione (GSH) content in rat liver. Biochem Pharmacol 29:1968-1970.
32. Begleiter A. 1985. Studies on the mechanism of action of quinone antitumor agents. Biochem Pharm 34:2629-2636.
33. Adelman R, Saul RL, Ames BN. 1988. Oxidative damage to DNA: Relation to species metabolic rate and life span. Proc Natl Acad Sei USA 85:2706-2708.
34. Wood JM, Schallreuter KU. 1991. Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Bioehim Biophys Acta 1074:378-385.
35. Vad NM, Moridani MY, Shaik IH, Mehvar R. 2007. Metabolic bioactivation and toxicity of ethyl 4-hydroxy benzoate in human SK-MEL-28 melanoma cells. J Pharm Sei 97:1934-1945.
36. Šimonova M, Wall A, Weissleder R, Bogdanov A, Jr. 2000. Tyrosinase mutants are capable of prodrug activation in transfeeted nonmelanotic cells. Can- cer Res 60:6656-6662.
37. Pieardo M, Passi S, Nazzaro-Porro M, Breathnach AS, Zompetta C, Faggioni A, Riley P. 1987. Mechanism of antitumoral activity of catechols in culture. Biochem Pharmacol 36:417-425.
38. Prota G, Nicolaus RA. 1967. On the biogenesis of phaeomelanins. In: Montangna W, Hu F, editors. Advances in biology of skin. Oxford: Pergamon Press, pp. 323-328.
39. Pawelek JM, Lerner A. 1978. 5, 6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 276:627-628.
40. Benathan M, Alvero-Jackson H, Mooy AM. 1992. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells. Melanoma Res 2:304-314.
41. Chem YM, Chavin W. 1974. Tyrosinase activity in highly pigmented human melanoma and in negro skin. Proc Soc Exp Biol Med 145:695-698.